Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,490 | -3,490 | 3,000 | N/A | N/A |
| Depreciation Amortization | 2,530 | 1,710 | 1,460 | N/A | N/A |
| Other Working Capital | -20,140 | 14,580 | 4,280 | N/A | N/A |
| Other Operating Activity | 970 | -580 | 30 | 0 | 0 |
| Operating Cash Flow | $-4,150 | $12,220 | $8,770 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,290 | -1,920 | -1,430 | N/A | N/A |
| Other Investing Activity | 15,360 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $2,070 | $-1,920 | $-1,430 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,080 | 74,430 | 400 | 0 | 0 |
| Financing Cash Flow | $5,080 | $74,430 | $400 | $N/A | $N/A |
| Exchange Rate Effect | 370 | 10,350 | 1,470 | N/A | N/A |
| Beginning Cash Position | 1,190 | 14,520 | 5,300 | N/A | N/A |
| End Cash Position | 4,590 | 109,610 | 14,520 | N/A | N/A |
| Net Cash Flow | $3,390 | $95,090 | $9,210 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,150 | 12,220 | 8,770 | N/A | N/A |
| Free Cash Flow | -4,150 | 12,220 | 8,770 | 0 | 0 |